Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.
Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.
These notes describe the products in the eCOA guide.
Kayentis
Best for
Phase II-III sponsors that want a specialist eCOA vendor with site and patient helpdesk support
What to consider
Kayentis is an eCOA specialist with 280+ trials in 85 countries and 120 languages, and its Clin'form app runs on BYOD, provisioned devices, web and interview mode. It does not publish build timelines, approval counts or prices.
CNS and other complex-endpoint trials that need clinician ratings, licensing support and global logistics
What to consider
Signant combines a 50+ instrument library, in-house licensing support and 50+ clinical and eCOA experts with operations in 135+ countries. It says it supported 25% of FDA and EMA novel drug approvals from 2020 to 2025 and now adds wearable sensors through Ametris. Builds are vendor-led and prices are not published.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Kayentis vs Signant eCOA (eCOA): category feature evidence and sources. Products are not ranked.
Category feature
Kayentis
Signant eCOA
Validated instrument library and licensingFeature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Kayentis
Extended support
Questionnaire library and translation tools built with linguistic validation agencies; licensing and validation handled with language-service partners.